ImmunityBio (IBRX) Other financing activities (2016 - 2026)
ImmunityBio (IBRX) recorded Other financing activities of $319,000 in Q2 2026, down 0.9% from $322,000 a year earlier and down 95.4% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Other financing activities (2016 - 2026) Analysis & Trends
On a TTM basis, ImmunityBio's Other financing activities came in at $8.05 million as of Jun 30, 2026, up 206.7% year-over-year; for FY2025, it was $2.27 million, down 58.6% from FY2024.
- Annual Other financing activities has a five-year compound annual growth rate of 35.1% (FY2020 to FY2025).
- Across earlier years, Other financing activities came in at $5.47 million in FY2024 (+58.7%), $3.44 million in FY2023 (+458.9%), $616,000 in FY2022 (-84.8%) and $4.06 million in FY2021 (+708.0%).
- Quarterly Other financing activities has ranged from $10,000 in Q3 2022 to $6.99 million in Q1 2026 over the past five years.
- On a year-over-year basis, Other financing activities rose in 1 of the last eight quarters, with growth averaging 21.6%.
- Peak year-over-year performance for Other financing activities in the last five years was growth of 983.2% in Q1 2024, against a decline of 99.0% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.99 million (Q1 2026), $590,000 (Q4 2025) and $151,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | ImmunityBio | 9.07 Bn | 7.83 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -319,000.00 |
| Mar 31, 2026 | -6.99 Mn |
| Dec 31, 2025 | -590,000.00 |
| Sep 30, 2025 | -151,000.00 |
| Jun 30, 2025 | -322,000.00 |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | -803,000.00 |
| Sep 30, 2024 | -299,000.00 |
| Jun 30, 2024 | -496,000.00 |
| Mar 31, 2024 | -3.87 Mn |
| Dec 31, 2023 | -1.56 Mn |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -60,000.00 |
| Mar 31, 2023 | -357,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Sep 30, 2022 | -349,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -372,000.00 |
| Dec 31, 2021 | -480,000.00 |
| Sep 30, 2021 | 56,000.00 |
API Access
ImmunityBio Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();